Home » Newsletters » BioWorld Asia

BioWorld Asia

June 14, 2000

View Archived Issues

European Biotech Fund Raising Lags, But Products Are Coming

Canada Invests In Virtual Medical Health Institutes

GenOdyssee Gathers $8.6M In Financing For SNP Effort

Taiwan Firm Invests $6.2 Million In Progen For Molecule Development

Peptide Therapeutics Has Positive Results In Phase III Arilvax Trial

Oxford, Aventis Extend Agreement In Cardiovascular Gene Therapy

British Biotech Pares 80 Jobs, With Saved Funds To Push Development

Scotia Gets Boost From Journal Backtracking On Foscan Data

European Industrialists Call For More Backing For Biotech

Transghne Receives $1 Million Milestone from Schering-Plough

ProChon, MorphoSys Form Deal Around Antibody Library

Genset Raises EUR49 Million In Private Placement Of Bonds

ICH Mulls Gene Therapy Rules, Common Application Format

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...